BPC-157 is a 15-residue pentadecapeptide, GEPPPGKPADDAGLV, 1419.53 g/mol, corresponding to a partial sequence of Body Protection Compound originally characterised in human gastric juice, and unusual among peptides of this length for resisting hydrolysis at low pH
- Mass Spectrometry: To verify molecular weight and sequence integrity
Is there transparency about compounding practices
Creams: Applied topically, easy to use but may have inconsistent absorption and require daily application and it is difficult to achieve levels high enough to provide desired results
Semaglutide commonly causes nausea, vomiting, diarrhea, and constipation
To compare the frequency difference between groups, the chi-square test or Fischers exact test was used